Retatrutide
Pre-approval Expanded Access of Retatrutide (LY3437943)
Eli Lilly · Phase n/r · Available · Enrollment n/r
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Registry arm not named | n/r | n/r | n/r | n/r |
Not shown
- Registry arm not named: endpoint not reported